CASEY BROWNING: Open Payments
NPI 1689009441 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 22 payments from 12 companies in 2025. Trend: 2023 $73 · 2024 $123 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $179 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $41 |
| BridgeBio Pharma, Inc. | 2 | $39 |
| Medtronic, Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Amgen Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: LEQVIO, Ozempic, LifeVest, Attruby, LINQ II, CAPVAXIVE, MITRACLIP, CAMZYOS.
Industry payments across IN — which companies pay providers there.
